Discovery+Phacilitate: Interview with Dominic Clarke, CTO of Cell and Gene Therapies
DOMINIC CLARKE, CTO OF CELL AND GENE THERAPIES AT DISCOVERY LIFE SCIENCES DISCUSSES THE IMPORTANCE OF A DIVERSE AND RELIABLE DONOR POOL IN THE DEVELOPMENT OF CELL THERAPIES, AND CONSIDERS THE SIGNIFICANCE OF THIS CONSISTENCY WHEN TRANSITIONING TO GMP-COMPLIANT PROCESSES.
February 16, 2022
Never Miss an Update
Sign up and receive Discovery updates, blogs, and market news directly to your inbox.Subscribe Now
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!